Quanterix Corporation Operating Lease Cost
Quanterix Corporation (QTRX) reported Operating Lease Cost of $5.97 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-03-02
- Quanterix Corporation operating lease, cost for the quarter ending 2022-12-31 was $1.75M, a 140.74% increase year-over-year.
- Quanterix Corporation operating lease, cost for the quarter ending 2022-09-30 was $1.50M, a 126.24% increase year-over-year.
- Quanterix Corporation operating lease, cost for the quarter ending 2022-06-30 was $1.57M, a 136.65% increase year-over-year.
- Quanterix Corporation operating lease, cost for the quarter ending 2022-03-31 was $663.00K, a 1.19% decline year-over-year.
- Quanterix Corporation operating lease, cost for fiscal 2025 was $5.97M, a 20.63% increase from fiscal 2024.
- Quanterix Corporation operating lease, cost for fiscal 2024 was $4.95M, a 4.99% decline from fiscal 2023.
- Quanterix Corporation operating lease, cost for fiscal 2023 was $5.21M, a 5.08% decline from fiscal 2022.
- Quanterix Corporation operating lease, cost for fiscal 2022 was $5.49M, a 101.32% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month | Operating Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $5.97M 10-K · filed 2026-03-02 | ||||
| 2024-12-31 | $4.95M 10-K · filed 2026-03-02 | ||||
| 2023-12-31 | $5.21M 10-K · filed 2026-03-02 | ||||
| 2022-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $3.25M derived: sum of 2 quarters · filed 2025-03-17 | $4.82M derived: sum of 3 quarters · filed 2025-03-17 | $5.49M 10-K · filed 2025-03-17 | $8.90M 10-K · filed 2023-03-06 |
| 2022-09-30 | $1.50M 10-Q · filed 2022-11-09 | $3.07M derived: sum of 2 quarters · filed 2022-11-09 | $3.73M 10-Q · filed 2022-11-09 | $4.46M derived: sum of 4 quarters · filed 2024-12-26 | |
| 2022-06-30 | $1.57M 10-Q · filed 2022-08-08 | $2.23M 10-Q · filed 2022-08-08 | $2.96M derived: sum of 3 quarters · filed 2024-12-26 | $3.62M derived: sum of 4 quarters · filed 2024-12-26 | |
| 2022-03-31 | $663.00K 10-Q · filed 2022-05-10 | $1.39M derived: sum of 2 quarters · filed 2024-12-26 | $2.06M derived: sum of 3 quarters · filed 2024-12-26 | $2.72M derived: sum of 4 quarters · filed 2024-12-26 | |
| 2021-12-31 | $729.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-26 | $1.39M derived: sum of 2 quarters · filed 2024-12-26 | $2.06M derived: sum of 3 quarters · filed 2024-12-26 | $2.73M 10-K/A · filed 2024-12-26 | $2.66M 10-K · filed 2022-03-01 |
| 2021-09-30 | $663.00K 10-Q · filed 2022-11-09 | $1.33M derived: sum of 2 quarters · filed 2022-11-09 | $2.00M 10-Q · filed 2022-11-09 | $4.80M derived: sum of 4 quarters · filed 2023-03-06 | |
| 2021-06-30 | $663.00K 10-Q · filed 2022-08-08 | $1.33M 10-Q · filed 2022-08-08 | $4.14M derived: sum of 3 quarters · filed 2023-03-06 | $4.81M derived: sum of 4 quarters · filed 2023-03-06 | |
| 2021-03-31 | $671.00K 10-Q · filed 2022-05-10 | $3.48M derived: sum of 2 quarters · filed 2023-03-06 | $4.14M derived: sum of 3 quarters · filed 2023-03-06 | $4.81M derived: sum of 4 quarters · filed 2023-03-06 | |
| 2020-12-31 | $2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $3.47M derived: sum of 2 quarters · filed 2023-03-06 | $4.14M derived: sum of 3 quarters · filed 2023-03-06 | $4.80M 10-K · filed 2023-03-06 | $2.66M 10-K · filed 2021-03-05 |
| 2020-09-30 | $667.00K 10-Q · filed 2021-11-04 | $1.33M derived: sum of 2 quarters · filed 2021-11-04 | $1.99M 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $667.00K 10-Q · filed 2021-08-05 | $1.33M 10-Q · filed 2021-08-05 | |||
| 2020-03-31 | $660.00K 10-Q · filed 2021-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |